Stock Analysts’ Upgrades for February, 15th (ACOR, ATVI, BBVA, CPLA, DCP, IPGP, LECO, MBLY, MC, MCC)

Stock Analysts’ upgrades for Wednesday, February 15th:

Acorda Therapeutics (NASDAQ:ACOR) was upgraded by analysts at Goldman Sachs Group, Inc. (The) from a conviction sell rating to a sell rating.

Activision Blizzard (NASDAQ:ATVI) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $53.00 target price on the stock. According to Zacks, “Activision reported fourth quarter results wherein both adjusted earnings and revenues beat the Zacks Consensus Estimate. However, management provided a subdued outlook for 2017 underscoring a “lighter slate” of releases in the year. Nonetheless, we believe the company’s enviable product portfolio that includes the likes of Call of Duty and World of Warcraft along with increasing digital revenues will continue to drive growth. Moreover, the company will continue to benefit from acquisition of King Digital. The company’s attempts to become a broad-based media company are prudent in our view. Apart from launching a movie studio and consumer products division, the company is also strengthening its presence in the lucrative e-sports market. Over the past one year, share prices have outperformed the Zacks categorized Toys/Games/Hobby Prod industry. “

Banco Bilbao Vizcaya Argentaria SA (NASDAQ:BBVA) was upgraded by analysts at J P Morgan Chase & Co from a neutral rating to an overweight rating.

Capella Education Company (NASDAQ:CPLA) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating. The firm currently has $84.00 target price on the stock.

DCP Midstream Partners, (NYSE:DCP) was upgraded by analysts at Credit Suisse Group from an underperform rating to a neutral rating.

IPG Photonics Corporation (NASDAQ:IPGP) was upgraded by analysts at Dougherty & Co from a neutral rating to a buy rating. Dougherty & Co currently has $137.00 target price on the stock.

Lincoln Electric Holdings (NASDAQ:LECO) was upgraded by analysts at Longbow Research from an underperform rating to a neutral rating.

Mobileye N.V. (NYSE:MBLY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Mobileye N.V. engages in designing and developing software and related technologies for camera-based advanced driver assistance systems. The company offers software algorithms and EyeQ chips that perform detailed interpretations of the visual field to anticipate possible collisions with other vehicles, pedestrians, cyclists, animals, debris, and other obstacles; and detect roadway markings, such as lanes, road boundaries, barriers, and related items, as well as identify and read traffic signs and traffic lights. Mobileye N.V. is headquartered in Jerusalem, Israel. “

Moelis & Company (NYSE:MC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $42.00 target price on the stock. According to Zacks, “Moelis & Company is a global independent investment bank. The Company provides innovative strategic advice and solutions to a diverse client base, including corporations, governments and financial sponsors. It advises clients in the areas of mergers and acquisitions, recapitalizations and restructurings, and other corporate finance matters. Moelis & Company is based in New York. “

Medley Capital Corporation (NYSE:MCC) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Medley Capital Corporation is a closed-end, externally managed investment company. Medley Capital Corporation’s objective is to generate current income and capital appreciation by lending directly to privately-held small and middle market companies to help these companies fund acquisitions, growth or refinancing. Their portfolio will generally consist of first lien senior secured loans, and, to a lesser extent, second lien secured loans. In many of their investments, they will get warrants or other equity participation features which they believe will increase the total investment returns. “

Medidata Solutions (NASDAQ:MDSO) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $66.00 price target on the stock. According to Zacks, “Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies. “

MacroGenics (NASDAQ:MGNX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. “

Merus Labs International (NASDAQ:MSLI) (TSE:MSL) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Merus Labs International Inc. is a specialty pharmaceutical company engaged in acquisition and licensing of pharmaceutical products. The Company’s products include anti-infectives and wound care products. Merus Labs International Inc., formerly known as Envoy Capital Group Inc., is based in Vancouver, Canada. “

Nordic American Offshore (NYSE:NAO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Nordic American Offshore Ltd. is an international offshore supply vessel company. The Company operates platform supply vessels (PSVs) which are part of the oil exploration business, transporting stores, provisions and equipment to offshore oil installations in such places as the North Sea, the Gulf of Mexico, the coast of Brazil and other locations where there are offshore oil activities. Nordic American Offshore Ltd. is based in Hamilton, Bermuda. “

Norwegian Cruise Line Holdings (NASDAQ:NCLH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $54.00 target price on the stock. According to Zacks, “Norwegian Cruise Line is a cruise line operator. It offers cruise itineraries in various locations, including destinations in the Caribbean, Bermuda, the Bahamas, Mexico, Alaska, Europe, Hawaii, New England, Central America, North Africa, and Scandinavia. The company markets its services primarily through retail/travel agents. Norwegian Cruise Line is headquartered in Miami, Florida. “

Noodles & Company (NASDAQ:NDLS) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Noodles & Company is a fast casual restaurant which offers lunch and dinner. It serves noodles, pastas, salads, soups, sandwiches, cheese, meatballs and beverages. The company operates in the United States. Noodles & Company is based in Broomfield, Colorado. “

Omega Healthcare Investors (NYSE:OHI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $36.00 price target on the stock. According to Zacks, “OMEGA HEALTHCARE INVESTORS is a self-administered real estate investment trust which invests in income- producing health care facilities, principally long-term care facilities, with the objective of profitable growth and further diversification of the investment portfolio. Investments are located primarily in the United States. “

Oceaneering International (NYSE:OII) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “OCEANEERING INTERNATIONAL, INC. is an advanced applied technology company that provides engineered services and hardware to customers who operate in marine, space and other harsh environments. The company supplies a comprehensive range of integrated technical services to a wide array of industries and is one of the world’s largest underwater services contractors. “

OneMain Holdings (NYSE:OMF) was upgraded by analysts at Wedbush from a neutral rating to an outperform rating. The firm currently has $35.00 target price on the stock, up from their previous target price of $30.00.

ON Semiconductor Corporation (NASDAQ:ON) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ON Semiconductor is a supplier of broadband and power management integrated circuits and standard semiconductors used in numerous advanced devices ranging from high-speed fiber optic networking equipment to the precise power management functions found in portable electronics. The company's expanding product portfolio helped it to report strong fourth-quarter 2016 results. Moreover, the company has outperformed the broader market over the last one-year. Further, the company’s improving end markets, completion of the Fairchild Semiconductor acquisition, product breadth, diversification across end markets and geographies, and the benefits of restructuring actions remain positives. However, ON Semi has a leveraged balance sheet and faces a good bit of competition, which are concerns. “

Open Text Corporation (NASDAQ:OTEX) (TSE:OTC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $38.00 price target on the stock. According to Zacks, “Open Text Corporation is engaged in development of innovative intranet, extranet and e-Business applications. Since creating one of the first search engines to index the World Wide Web, the company has remained at the forefront of Internet-based technologies. Open Text solutions allow individuals, teams, organizations, and global trading communities to collaborate on projects, share ideas and accelerate innovation to the fastest possible speed. Open Text Corporation is headquartered in Waterloo, Canada. “

Punch Taverns (NASDAQ:PCTVY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Punch Taverns plc owns, leases and tenanted pubs primarily in the United Kingdom. The company also leases licensed properties, offices, other commercial properties and other assets. Punch Taverns plc is based in Burton-upon-Trent, the United Kingdom. “

Pernod Ricard SA (OTCMKTS:PDRDY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Pernod Ricard SA, based in France, operates as a manufacturer and seller of a wide range of wines and spirits. The company operates as holding company, with the structure divided between brand owner subsidiaries, such as The Absolut Company, Havana Club International and Chivas Brothers, which produce and develop marketing strategies for the brands, and regional distribution subsidiaries, such as Pernod Ricard Europe, Pernod Ricard Americas and Pernod Ricard Asia, which implement marketing strategies and distribute local brands. The Company is active in eight principal beverage sectors: whiskies, aniseed spirits, liqueurs, cognacs and brandies, white spirits and rums, bitters, champagnes and wines. Pernod Ricard SA’s flagship brands include Ricard, Havana Club, Ballantine’s, Malibu, Martell, The Glenlivet, Chivas Regal, Jameson and Absolut Vodka, among others. “

Parker-Hannifin Corporation (NYSE:PH) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. The firm currently has $180.00 price target on the stock.

PJT Partners (NYSE:PJT) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. They currently have $42.00 price target on the stock. According to Zacks, “PJT Partners Inc. is a financial advisory firm. The Company offers strategic advisory, restructuring and reorganization, fund placement and funds advisory services to corporations, financial sponsors, institutional investors and governments. PJT Partners Inc. is based in NEW YORK, United States. “

Pluristem Therapeutics (NASDAQ:PSTI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $1.25 target price on the stock. According to Zacks, “PLURISTEM THERAPEUTICS INC. is a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. The Company is developing a pipeline of products, stored ready-to-use, that are derived from the human placenta, a non-controversial source, and not from embryonic stem cells. “

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Reckitt Benckiser Group Plc engages in manufacturing and distributing household, toiletry, pharmaceutical and food products. The company offers antiseptic liquids, depilatory products, medicated sore throat products, condoms, cold/flu products, acne treatment products, analgesics and upper gastro-intestinal products, foot care and comfort footwear products, denture care and dry skin care products, fabric care products, surface care products and polishes/waxes. Reckitt Benckiser Group is based in Slough, the United Kingdom. “

Regency Centers Corporation (NYSE:REG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $80.00 price target on the stock. According to Zacks, “Backed by better-than-expected growth in revenue, Regency Centers’ fourth-quarter 2016 core funds from operations (FFO) per share came ahead of the Zacks Consensus. Moreover, it experienced growth in same property net operating income (SPNOI). Regency’s focus on building a premium portfolio of grocery-anchored shopping centers augurs well for the long term. Such centers are usually necessity driven and attract huge traffic. Further, the pending merger with Equity One is expected to bolster the company’s position in the retail real estate market and offer it solid scope for long-term growth. In addition, over the past three months, the shares of Regency outperformed the Zacks categorized REIT and Equity Trust – Retail industry. Further, the company’s estimate for full year 2017 and 2018 FFO per share climbed north over the past 30 days, indicating better prospect for the stock going forward.”

Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Regeneron’s fourth-quarter results were disappointing with the company missing on both earnings and revenues estimates. Moreover, the guidance for Eylea was also weak. Regeneron suffered a major blow when the U.S District Court in Delaware granted Amgen request for a permanent injunction prohibiting the sale of PCSK9 inhibitor, Praluent. However, on Feb 8, the United States Court of Appeals for the Federal Circuit stayed the injunction appeal. Hence, Regeneron and Sanofi will continue marketing, selling, and manufacturing Praluent in the U.S. during the appeal process. Although sales of Praluent have failed to impress due to the present payer utilization management restrictions in the U.S. and limited market access in Europe, the drug is still expected to have blockbuster potential. Investors should focus on late stage pipeline catalysts – dupilumab and sarilumab. Shares of the company have also underperformed the industry.”

Real Industry (NASDAQ:RELY) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Real Industry, Inc. is a holding company which invests in businesses primarily in the United States industrial and commercial marketplace. Real Industry Inc., formerly known as Signature Group Holdings, Inc., is based in Sherman Oaks, United States. “

RELX N.V. (NYSE:RENX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “RELX NV provides professional information solutions primarily in North America and Europe. The company’s operating segments consists of Scientific, Technical & Medical; Risk & Business Information; Legal, and Exhibitions. Scientific, Technical & Medical segment provides information and tools to help customers improve scientific and healthcare outcomes. Risk & Business Information segment provides data and analytics which enable customers to evaluate and manage risk. Legal segment provides legal, regulatory, news, business information and analysis to legal, corporate, Government and academic customers. Exhibitions segment, through the subsidiary Reed Exhibitions, organizes market events relevant to industry needs. RELX NV, formerly known as Reed Elsevier NV, is based in Amsterdam, the Netherlands. “

Royal Bank Of Canada (NYSE:RY) (TSE:RY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $83.00 target price on the stock. According to Zacks, “ROYAL BANK of Canada operate under the master brand name of RBC. They are Canada’s largest bank as measured by assets and market capitalization, and one of North America’s leading diversified financial services companies. They provide personal and commercial banking, wealth management services, insurance, corporate and investment banking, and transaction processing services on a global basis. They have employee approximately Seventy Thousant full- and part-time employees who serve more than 15 million personal, business, public sector and institutional clients through offices in Canada, the U.S. and 36 other countries. “

Swisscom AG (NASDAQ:SCMWY) was upgraded by analysts at Zacks Investment Research from a sell rating to a strong-buy rating. The firm currently has $51.00 price target on the stock. According to Zacks, “Swisscom is Switzerland’s leading telecommunications company. The innovative, customer-focused and strongly-competitive group offers a full range of voice and data communication services on fixed-line and mobile networks. Swisscom offers the complete spectrum of state-of-the-art data services, from leased lines to integrated solutions for corporate customers. “

COMSCORE (NASDAQ:SCOR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $26.00 target price on the stock. According to Zacks, “ComScore, Inc. is a global leader in measuring the digital world. This capability is based on a massive, global cross-section of more than two million consumers who have given comScore permission to confidentially capture their browsing and transaction behavior, including online and offline purchasing. comScore panelists also participate in survey research that captures and integrates their attitudes and intentions. Through its proprietary technology, comScore measures what matters across a broad spectrum of behavior and attitudes. comScore analysts apply this deep knowledge of customers and competitors to help clients design powerful marketing strategies and tactics that deliver superior ROI. comScore services are used by global leaders such as AOL, Microsoft, Yahoo!, Verizon, Best Buy, The Newspaper Association of America, Tribune Interactive, ESPN, Fox Sports, Nestle, MBNA, Starcom USA, Universal McCann, the United States Postal Service, Merck and Expedia. “

Softbank Corp. (OTCMKTS:SFTBY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $43.00 target price on the stock. According to Zacks, “SOFTBANK CORP. is engaged in providing telecommunication services. The Company’s business segments include: Mobile Communication, Broadband Infrastructure, Fixed-line Communication, Internet Culture and Others. It provides mobile communication services and sells attached cellular phone terminals, high-speed Internet access services, Internet protocol (IP) phone services and contents, fixed communication service, Internet advertising business, operation of various electronic commerce sites, provision of membership services, distribution of software and peripheral devices for personal computers and the operation of Fukuoka SoftBank Hawks-related business. SOFTBANK CORP. is headquartered in Tokyo, Japan. “

Sage Group Unspon (NASDAQ:SGPYY) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “The Sage Group plc supplies business management software, services and support to small and medium sized businesses. The Company’s products includes accounting, payroll, customer relationship management, financial forecasting, payment processing, job costing, human resources, business intelligence, taxation and other products for accountants, business stationery, development platforms, e-business and enterprise resource planning. Sage Group’s products find its application in the healthcare, human resource and payroll, construction/real estate, transport/distribution, payment processing, accountancy, manufacturing, retail, and automotive distribution industries. The products offered by the Company are majorly developed and supported locally. The Sage Group plc is headquartered in Newcastle upon Tyne, the United Kingdom. “

Sutherland Asset Management Corp. (NYSE:SLD) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $15.00 target price on the stock. According to Zacks, “Sutherland Asset Management Corporation is a commercial mortgage REIT. The company is a real estate finance company which acquires, originates, manages, services and finances primarily small balance commercial loans. It also invests in asset-backed securities and other real estate-related investments. Sutherland Asset Management Corporation, formerly known as ZAIS Financial Corp., is based in New York. “

Southern National Bancorp of Virginia (NASDAQ:SONA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Headquartered in Charlottesville Virginia, Sonabank is a new regional bank founded by an experienced banking team with close to hundred years of banking experience. They offer a full line of products and services for personal and business banking. Sonabank specializes in small to medium sized business banking. They have extensive experience in Small Business Administration loans as well as other types of financing suited for businesses. “

Sierra Wireless (NASDAQ:SWIR) (TSE:SW) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $28.00 price target on the stock. According to Zacks, “Sierra Wireless, Inc. is a leading provider of wireless data communications products. The company delivers wireless PC Cards for portable computers, wireless adapters for PDA’s, OEM modules for embedded applications and rugged vehicle-mounted wireless systems. The company is the founding member of the WirelessReady Alliance, an alliance of industry-leading hardware, software and service companies committed to the delivery of complete and compelling wireless data solutions. “

Orchids Paper Products Company (NYSEMKT:TIS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Orchids Paper Products Company is a tissue paper company that manufacturers and converts tissue product for the private label consumer market. “

Titan Machinery (NASDAQ:TITN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $15.00 price target on the stock. According to Zacks, “Titan Machinery represents a diversified mix of agricultural, construction, and consumer products dealerships located in the upper Midwest. Their Shared Resource Headquarters is located in the heart of the Red River Valley in Fargo, ND. Titan Machinery is a dealer for Case IH, Case Construction, New Holland, and New Holland Construction. Titan Machinery also represents shortline equipment to meet specialized customer demand and niche product needs. “

Teligent (NASDAQ:TLGT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $8.00 target price on the stock. According to Zacks, “Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey. “

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/stock-analysts-upgrades-for-february-15th-acor-atvi-bbva-cpla-dcp-ipgp-leco-mbly-mc-mcc/1662104.html

Receive News & Ratings for Acorda Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acorda Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *